231 related articles for article (PubMed ID: 18500561)
1. Chitosan and enteric polymer based once daily sustained release tablets of aceclofenac: in vitro and in vivo studies.
Mutalik S; Manoj K; Reddy MS; Kushtagi P; Usha AN; Anju P; Ranjith AK; Udupa N
AAPS PharmSciTech; 2008; 9(2):651-9. PubMed ID: 18500561
[TBL] [Abstract][Full Text] [Related]
2. Preparation, in vitro, preclinical and clinical evaluations of once daily sustained release tablets of aceclofenac.
Mutalik S; Naha A; Usha AN; Ranjith AK; Musmade P; Manoj K; Anju P; Prasanna S
Arch Pharm Res; 2007 Feb; 30(2):222-34. PubMed ID: 17366745
[TBL] [Abstract][Full Text] [Related]
3. Formulation development and optimization of bilayer tablets of aceclofenac.
Dey S; Mahanti B; Khila S; Mazumder B; Gupta SD
Expert Opin Drug Deliv; 2012 Sep; 9(9):1041-50. PubMed ID: 22788786
[TBL] [Abstract][Full Text] [Related]
4. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
Emara LH; Taha NF; Badr RM; Mursi NM
Drug Discov Ther; 2012 Oct; 6(5):269-77. PubMed ID: 23229148
[TBL] [Abstract][Full Text] [Related]
5. Preparation and, in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates.
Usha AN; Mutalik S; Reddy MS; Ranjith AK; Kushtagi P; Udupa N
Eur J Pharm Biopharm; 2008 Oct; 70(2):674-83. PubMed ID: 18606224
[TBL] [Abstract][Full Text] [Related]
6. Dual release and molecular mechanism of bilayered aceclofenac tablet using polymer mixture.
Van Nguyen H; Nguyen VH; Lee BJ
Int J Pharm; 2016 Dec; 515(1-2):233-244. PubMed ID: 27744034
[TBL] [Abstract][Full Text] [Related]
7. Modulation of microenvironmental pH for dual release and reduced in vivo gastrointestinal bleeding of aceclofenac using hydroxypropyl methylcellulose-based bilayered matrix tablet.
Kang WH; Nguyen HV; Park C; Choi YW; Lee BJ
Eur J Pharm Sci; 2017 May; 102():85-93. PubMed ID: 28263912
[TBL] [Abstract][Full Text] [Related]
8. Inulin-based tablet in capsule device for variable multipulse delivery of aceclofenac: optimization and in vivo roentgenography.
Sharma P; Pathak K
AAPS PharmSciTech; 2013 Jun; 14(2):736-47. PubMed ID: 23615771
[TBL] [Abstract][Full Text] [Related]
9. STUDYING THE IMPACT OF FORMULATION AND PROCESSING PARAMETERS ON THE RELEASE CHARACTERISTICS FROM HYDROXYPROPYL METHYLCELLULOSE MATRIX TABLETS OF DICLOFENAC.
Elzayat EM; Abdel-Rahman AA; Ahmed SM; Alanazi FK; Habib WA; Sakr A
Acta Pol Pharm; 2016; 73(2):439-52. PubMed ID: 27180437
[TBL] [Abstract][Full Text] [Related]
10. Design and evaluation of matrix-based controlled release tablets of diclofenac sodium and chondroitin sulphate.
Avachat A; Kotwal V
AAPS PharmSciTech; 2007 Oct; 8(4):E88. PubMed ID: 18181548
[TBL] [Abstract][Full Text] [Related]
11. A novel multi-unit tablet for treating circadian rhythm diseases.
Liu Q; Gong Y; Shi Y; Jiang L; Zheng C; Ge L; Liu J; Zhu J
AAPS PharmSciTech; 2013 Jun; 14(2):861-9. PubMed ID: 23649996
[TBL] [Abstract][Full Text] [Related]
12. Chitosan microspheres of aceclofenac: in vitro and in vivo evaluation.
Nagda C; Chotai N; Patel S; Nagda D; Patel U; Soni T
Pharm Dev Technol; 2010; 15(5):442-51. PubMed ID: 20735299
[TBL] [Abstract][Full Text] [Related]
13. Sustained release of amoxicillin from ethyl cellulose-coated amoxicillin/chitosan-cyclodextrin-based tablets.
Songsurang K; Pakdeebumrung J; Praphairaksit N; Muangsin N
AAPS PharmSciTech; 2011 Mar; 12(1):35-45. PubMed ID: 21161458
[TBL] [Abstract][Full Text] [Related]
14. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.
Savaşer A; Ozkan Y; Işimer A
Farmaco; 2005 Feb; 60(2):171-7. PubMed ID: 15752476
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of crosslinked chitosan hydrogel beads as a carrier for prolonged delivery of diclofenac sodium: in vitro and in vivo studies.
Alsarra IA
Boll Chim Farm; 2004 Dec; 143(10):359-64. PubMed ID: 15881815
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo studies on HPMC-K-100 M matrices containing naproxen sodium.
Kumar SM; Chandrasekar MJ; Gopinath R; Srinivasan R; Nanjan MJ; Suresh B
Drug Deliv; 2007 Mar; 14(3):163-9. PubMed ID: 17454036
[TBL] [Abstract][Full Text] [Related]
17. Preparation and evaluation of once-daily sustained-release coated tablets of tolterodine-L-tartrate.
Pradhan R; Kim YI; Chang SW; Kim JO
Int J Pharm; 2014 Jan; 460(1-2):205-11. PubMed ID: 24184032
[TBL] [Abstract][Full Text] [Related]
18. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of a time-specific pulsatile-release tablet of aceclofenac: a solution for morning pain in rheumatoid arthritis.
Qureshi J; Ahuja A; Baboota S; Chutani K; Jain S; Ali J
Methods Find Exp Clin Pharmacol; 2009; 31(1):15-23. PubMed ID: 19357794
[TBL] [Abstract][Full Text] [Related]
20. Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drug--an in vitro and an in vivo study.
M K; Sistla R; Shastri NR
Drug Deliv; 2015 May; 22(3):418-26. PubMed ID: 24471823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
